Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated human recombinant arginase

pegylated arginase
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated human recombinant arginase, covering 2012-03-14 to 2012-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pegylated Human Recombinant Arginase for Liver Cancer [Phase 1]

See pricing